Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Asthma Phenotypes

Home Severe Asthma Asthma Phenotypes

Asthma Phenotypes

Asthma is heterogeneous, meaning that there are many different types of asthma, across the whole range of severity from mild to severe. Recognisable clusters of demographic features, clinical characteristics, lung function and inflammation are called “asthma phenotypes”.

For example, some well-recognised clinical asthma phenotypes include:

Examples of clinical asthma phenotypes table, allergic asthma, late onset asthma

These different types of asthma, although they produce similar symptoms, are likely to have different underlying mechanisms. In the severe asthma population, it is becoming increasingly important to carefully characterise the features of asthma in individual patients, in order to identify potential treatment options. These mechanisms are complex.

Asthma phenotypes can also be defined based on the patterns of inflammation and immune cell types that are present.

Some well-recognised inflammatory asthma phenotypes include:

Identification of individual features of disease can provide insights into disease mechanisms and can be predictive for a patient’s response to treatment. A number of different clinical assessments can be performed to characterise phenotypes, including sputum assessment and characterisation of other biomarkers. For more information see Diagnosis and Assessment; Phenotyping.

In particular, new targeted therapies (e.g. monoclonal antibody therapy) work by blocking specific pathways that are active in specific subsets of patients. Thus, a detailed assessment of biomarkers that may identify these pathways is required before administering these treatments for each individual.

Additional Resources:

  • Inflammation Biomarkers in the Assessment and Management of Severe Asthma – Tools and Interpretation: This document provides an overview of fractional exhaled nitric oxide (FeNO) and eosinophil numbers as biomarkers to inform asthma management, including assessment approaches and interpretation of findings.
Click here to download a printable version of the infographic below.

Access the full suite of infographics here.

severe asthma phenotype infographic
Previous
Diagnosis & Assessment

Last Updated on July 7, 2021

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Overview
  • Definition
  • Prevalence & Burden
  • Pathophysiology
  • Symptoms
  • Severe Asthma Attacks / Exacerbations / Flare-ups
  • Asthma Phenotypes

What is Severe Asthma?

It is asthma that remains uncontrolled despite treatable factors having been addressed and maximal inhaled therapy being taken regularly.

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia